DRUG INDUSTRY

Addresses

Korean Intellectual Property Rights at the Crossroad: Robert H. Malott, 33526 [21OC]

National Drug Trade Conference Anniversary: James D. Cope, 16288-16290 [28JN]

Advertisements

Six-Day Therapy of Tumorex, 8876 [27AP]

Agreements

Investigation of new drugs: FDA and Herschel Zackheim, 30637 [14OC]

Amendments

Animal drugs: new drug applications and authorizing new patents (S. 2843), 30272, 30401 [13OC]

Articles and editorials

Company Offers Free Medicine to Needy Heart Patients, 10176 [9MY]

Company To Give Heart Drugs to Needy Dallas-Area Patients, 9812 [3MY]

Congress' Unpretentious Program for Orphan Drugs, 19592 [29JY]

Drug Giveaway Praised, 8766 [26AP]

Forcing Poverty on AIDS Patients, 23718 [14SE]

Influence of Abortion Critics Barring Sale of Drug in U.S., 14496 [14JN]

Needy To Receive Free Heart Drugs—Pharmaceutical Company To Give Medicine to People Who Cannot Afford It, 9795 [3MY]

Orphan Drug Act—A Program That's Working, 11905 [20MY]

OU Scientists Study the French Drug, 14495 [14JN]

Pharmaceutical Firm Offers Free Drugs to District Needy, 9171 [27AP]

RU 486—Death Pill or New Contraceptive?, 14494 [14JN]

U.S.-Made Chemicals Supply Narcotics Labs Across Latin America—Industry Says It Shuns Buyers It Suspects, but Somehow Shipments Keep Booming, 27447 [3OC]

Bills and resolutions

Animal drugs: new drug applications and authorizing new patents (see S. 2843; H.R. 4714)

———new drug applications and authorizing new patents (S. 2843), correcting enrollment (see H. Con. Res. 394)

Crime and criminals: preventing manufacturing and distribution of illegal substances (see H.R. 5582)

Federal Food, Drug and Cosmetic Act: anniversary of passage (see S.J. Res. 320)

Physicians: exclusion from medicare and State health programs for violations of regulations governing investigation of new drugs (see H.R. 5530)

Regulation: medicinal devices (see H.R. 4640)

Tariff: suspend duty on norfloxacin (see S. 2802)

Letters

Animal drug and patent amendments: several livestock and poultry organizations, 12765 [26MY]

Safety of Ritalin: Duane Alexander, NIH, 14746 [15JN]

———Hugh A. Cannon, FDA, 14745 [15JN]

———John C. Law, DEA, 15011 [16JN]

Lists

Organizations supporting funding for development of drugs for rare diseases, 19593 [29JY]

Memorandums

Use of Misoprostil: Dept. of HHS, 29967 [12OC]

Questions and answers

Safety of Ritalin: FDA, 14745 [15JN]

Remarks in House

Animal drugs: new abbreviated applications and extend patents (H.R. 4714), 12764 [26MY]

———new drug applications and authorizing new patents (S. 2843), 30554 [13OC]

———new drug applications and authorizing new patents (S. 2843), correcting enrollment (H. Con. Res. 394), 32777 [21OC]

Birth control: prohibit use of FDA funds for testing of mifepristone, 14494 [14JN]

Chemicals: diversion for illicit drug laboratories, 18531 [14JY]

Epilepsy: anniversary of introduction of anticonvulsant drug dilantin, 3706 [14MR]

FDA: enhancement of operations, 33451 [21OC]

Federal Food, Drug and Cosmetic Act: anniversary (H.J. Res. 600), 17402 [11JY]

G.D. Searle & Co.: Patients in Need Program, 9171 [27AP]

———tribute, 10176 [9MY]

Intellectual Property Owners, Inc.: Inventor of the Year awards, 6999 [14AP]

Merck & Co., Inc.: tribute, 7514 [19AP]

Orphan drugs: amendment (H.R. 3459), 3692 [10MR], 4733, 4734, 4736 [22MR]

Physicians: exclusion from medicare and State health programs for violations of regulations governing investigation of new drugs (H.R. 5530), 30637 [14OC]

Regulation: medicinal devices (H.R. 4640), 18884-18888 [26JY]

Ritalin: safety in treatment of attention deficit disorder in children, 14745 [15JN]

Remarks in Senate

Animal drugs: new drug applications and authorizing new patents (S. 2843), 25931, 26023 [28SE], 30272 [13OC]

AZT (Retrovir): cost for impoverished AIDS patients, 23716 [14SE]

———Federal subsidy, 29701 [11OC]

Courts: extend and improve procedures for liability and indemnification for nuclear incidents (H.R. 1414), 21978 [11AU]

FDA: marketing of misoprostil, 29967 [12OC]

Federal Food, Drug and Cosmetic Act: anniversary of passage (S.J. Res. 320), 11502 [18MY]

G.D. Searle & Co.: Patients in Need Program, 10273 [10MY]

———tribute, 8766 [26AP]

Merck Sharp & Dohme Research Laboratories: discovery of cholesterol-lowering drug, 6951 [14AP]

Orphan Drug Act: Federal grants for research, 11904 [20MY]

Prescription Drug Marketing Act: enact (H.R. 1207), 6208 [31MR]

Tariff: suspend duty on norfloxacin (S. 2802), 24201 [16SE]

Reports filed

AIDS Drugs—Where Are They? Committee on Government Operations (H. Rept. 100-1092), 31973 [19OC]

Animal Drug Applications: Committee on the Judiciary (H.R. 4982) (H. Rept. 100-972), 26817 [29SE]

Federal Asset Disposition Association's Deficient Regulation of the New Drug Versed: Committee on Government Operations (H. Rept. 100-1086), 30598 [13OC]

Prescription Drug Marketing Act: Committee on Finance (H.R. 1207) (S. Rept. 100-303), 4435 [18MR]

Regulation of Medicinal Devices: Committee on Energy and Commerce (H.R. 4640) (H. Rept. 100-782), 18924 [26JY]

Texts of

H. Con. Res. 394, correcting enrollment of S. 2843, new animal drug applications and authorizing new patents for animal drug products, 32777 [21OC]

H.R. 4640, regulation of medicinal devices, 18884-18887 [26JY]

S. 2802, suspend tariff on drug norfloxacin, 24201 [16SE]

S. 2843, new animal drug applications and authorizing new patents for animal drug products, 30554-30560 [13OC]

S.J. Res. 320, anniversary of passage of Federal Food, Drug and Cosmetic Act, 11502 [18MY], 18810 [26JY]